- Home
- DWSN vs PLRX Comparison
DWSN vs PLRX Comparison
Compare DWSN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWSN
- PLRX
- Stock Information
- Founded
- DWSN 1952
- PLRX 2015
- Country
- DWSN United States
- PLRX United States
- Employees
- DWSN N/A
- PLRX N/A
- Industry
- DWSN Oil & Gas Production
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- DWSN Energy
- PLRX Health Care
- Exchange
- DWSN Nasdaq
- PLRX Nasdaq
- Market Cap
- DWSN 89.9M
- PLRX 93.3M
- IPO Year
- DWSN N/A
- PLRX 2020
- Fundamental
- Price
- DWSN $1.78
- PLRX $1.52
- Analyst Decision
- DWSN
- PLRX Hold
- Analyst Count
- DWSN 0
- PLRX 10
- Target Price
- DWSN N/A
- PLRX $3.93
- AVG Volume (30 Days)
- DWSN 53.4K
- PLRX 420.6K
- Earning Date
- DWSN 11-11-2025
- PLRX 11-06-2025
- Dividend Yield
- DWSN N/A
- PLRX N/A
- EPS Growth
- DWSN N/A
- PLRX N/A
- EPS
- DWSN N/A
- PLRX N/A
- Revenue
- DWSN $55,987,000.00
- PLRX N/A
- Revenue This Year
- DWSN N/A
- PLRX N/A
- Revenue Next Year
- DWSN N/A
- PLRX N/A
- P/E Ratio
- DWSN N/A
- PLRX N/A
- Revenue Growth
- DWSN N/A
- PLRX N/A
- 52 Week Low
- DWSN $1.08
- PLRX $1.10
- 52 Week High
- DWSN $5.54
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- DWSN 56.60
- PLRX 49.18
- Support Level
- DWSN $1.75
- PLRX $1.42
- Resistance Level
- DWSN $1.86
- PLRX $1.55
- Average True Range (ATR)
- DWSN 0.11
- PLRX 0.08
- MACD
- DWSN -0.00
- PLRX -0.00
- Stochastic Oscillator
- DWSN 43.40
- PLRX 62.50
About DWSN Dawson Geophysical Company
Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.